Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Warner Bros. Discovery, Inc. Director's Dealing 2017

Jan 19, 2017

30161_dirs_2017-01-19_b6f2684c-f48c-4293-b558-daa45cb91aef.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Discovery Communications, Inc. (DISCA)
CIK: 0001437107
Period of Report: 2017-01-17

Reporting Person: Zaslav David (Director, Chief Executive Officer & Pres)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-01-17 Series A Common Stock M 289270 $26.38 Acquired 1111603 Direct
2017-01-17 Series A Common Stock D 216952 $27.69 Disposed 894651 Direct
2017-01-17 Series A Common Stock D 68897 $27.69 Disposed 825754 Direct
2017-01-17 Series A Common Stock F 1909 $27.81 Disposed 823845 Direct
2017-01-17 Series C Common Stock M 289270 $25.17 Acquired 1096741 Direct
2017-01-17 Series C Common Stock D 216952 $27.03 Disposed 879789 Direct
2017-01-17 Series C Common Stock D 67342 $27.03 Disposed 812447 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-01-17 Cash-Settled Stock Appreciation Right $33.0719 M 462241 Disposed 2017-01-31 Series A Common Stock (462241) Direct
2017-01-17 Cash- and Stock-Settled Stock Appreciation Right $43.9199 M 925665 Disposed 2018-01-31 Series A Common Stock (925665) Direct
2017-01-17 Cash- and Stock-Settled Stock Appreciation Right $33.17 M 231416 Disposed 2019-01-31 Series A Common Stock (231416) Direct
2017-01-17 Cash- and Stock-Settled Stock Appreciation Right $26.38 M 289270 Disposed 2020-01-31 Series A Common Stock (289270) Direct
2017-01-17 Cash- and Stock-Settled Stock Appreciation Right $27.69 A 1446351 Acquired 2021-01-31 Series A Common Stock (1446351) Direct
2017-01-17 Cash-Settled Stock Appreciation Right $32.0781 M 462241 Disposed 2017-01-31 Series C Common Stock (462241) Direct
2017-01-17 Cash- and Stock-Settled Stock Appreciation Right $42.6001 M 925665 Disposed 2018-01-31 Series C Common Stock (925665) Direct
2017-01-17 Cash- and Stock-Settled Stock Appreciation Right $32.28 M 231416 Disposed 2019-01-31 Series C Common Stock (231416) Direct
2017-01-17 Cash- and Stock-Settled Stock Appreciation Right $25.17 M 289270 Disposed 2020-01-31 Series C Common Stock (289270) Direct
2017-01-17 Cash- and Stock-Settled Stock Appreciation Right $27.03 A 1446351 Acquired 2021-01-31 Series C Common Stock (1446351) Direct

Footnotes

F1: The Cash- and Stock-Settled Stock Appreciation Rights in respect of these shares of stock vested and became payable, 75% in cash and 25% in Series A Common Stock on January 2, 2017. Under the terms of the Cash-and Stock-Settled Stock Appreciation Rights, however, the amounts payable in respect of the vested units could not be calculated until 10 trading days had passed from the vesting date.

F2: These shares represent the shares deemed disposed of to the Issuer upon the exercise of the cash-settled portion of the Cash- and Stock-Settled Appreciation Right.

F3: These shares represent the shares deemed disposed of to the Issuer to cover the exercise price of the stock-settled portion of the Cash- and Stock-Settled Stock Appreciation Right.

F4: These shares represent the shares disposed of to the Issuer to cover the applicable tax withholding related to the exercise of the stock-settled portion of the Cash- and Stock-Settled Stock Appreciation Right.

F5: The Cash- and Stock-Settled Stock Appreciation Rights in respect of these shares of stock vested and became payable, 75% in cash and 25% in Series C Common Stock on January 2, 2017. Under the terms of the Cash-and Stock-Settled Stock Appreciation Rights, however, the amounts payable in respect of the vested units could not be calculated until 10 trading days had passed from the vesting date.

F6: No amounts were payable in respect of these Cash-Settled Stock Appreciation Rights because the beginning unit value of $33.0719 per Unit exceeded the ending unit value of $27.69 per Unit.

F7: The Cash-Settled Stock Appreciation Rights vest in four equal annual installments beginning on January 2, 2014. On each vesting date, the Cash-Settled Stock Appreciation Rights are automatically settled in cash without action required by the Reporting Person.

F8: No amounts were payable and no shares were issued in respect of these Cash- and Stock-Settled Stock Appreciation Rights because the beginning unit value of $43.9199 per Unit exceeded the ending unit value of $27.69 per Unit.

F9: The Cash- and Stock-Settled Stock Appreciation Rights vest in four equal annual installments beginning on January 2, 2015. On each vesting date, the vested Cash- and Stock-Settled Stock Appreciation Rights are automatically settled, 75% in cash and 25% in Series A Common Stock without any action required by the Reporting Person.

F10: No amounts were payable and no shares were issued in respect of these Cash- and Stock-Settled Stock Appreciation Rights because the beginning unit value of $33.17 per Unit exceeded the ending unit value of $27.69 per Unit.

F11: The Cash- and Stock-Settled Stock Appreciation Rights vest in four equal annual installments beginning on January 2, 2016. On each vesting date, the vested Cash- and Stock-Settled Stock Appreciation Rights are automatically settled, 75% in cash and 25% in Series A Common Stock without any action required by the Reporting Person.

F12: The Cash- and Stock-Settled Stock Appreciation Rights vest in four equal annual installments beginning on January 2, 2017. On each vesting date, the vested Cash- and Stock-Settled Stock Appreciation Rights are automatically settled, 75% in cash and 25% in Series A Common Stock without any action required by the Reporting Person.

F13: The Cash- and Stock-Settled Stock Appreciation Rights vest in four equal annual installments beginning on January 2, 2018. On each vesting date, the vested Cash- and Stock-Settled Stock Appreciation Rights are automatically settled, 75% in cash and 25% in Series A Common Stock without any action required by the Reporting Person.

F14: No amounts were payable in respect of these Cash-Settled Stock Appreciation Rights because the beginning unit value of $32.0781 per Unit exceeded the ending unit value of $27.03 per Unit.

F15: No amounts were payable and no shares were issued in respect of these Cash- and Stock-Settled Stock Appreciation Rights because the beginning unit value of $42.6001 per Unit exceeded the ending unit value of $27.03 per Unit.

F16: The Cash- and Stock-Settled Stock Appreciation Rights vest in four equal annual installments beginning on January 2, 2015. On each vesting date, the vested Cash- and Stock-Settled Stock Appreciation Rights are automatically settled, 75% in cash and 25% in Series C Common Stock without any action required by the Reporting Person.

F17: No amounts were payable and no shares were issued in respect of these Cash- and Stock-Settled Stock Appreciation Rights because the beginning unit value of $32.28 per Unit exceeded the ending unit value of $27.03 per Unit.

F18: The Cash- and Stock-Settled Stock Appreciation Rights vest in four equal annual installments beginning on January 2, 2016. On each vesting date, the vested Cash- and Stock-Settled Stock Appreciation Rights are automatically settled, 75% in cash and 25% in Series C Common Stock without any action required by the Reporting Person.

F19: The Cash- and Stock-Settled Stock Appreciation Rights vest in four equal annual installments beginning on January 2, 2017. On each vesting date, the vested Cash- and Stock-Settled Stock Appreciation Rights are automatically settled, 75% in cash and 25% in Series C Common Stock without any action required by the Reporting Person.

F20: The Cash- and Stock-Settled Stock Appreciation Rights vest in four equal annual installments beginning on January 2, 2018. On each vesting date, the vested Cash- and Stock-Settled Stock Appreciation Rights are automatically settled, 75% in cash and 25% in Series C Common Stock without any action required by the Reporting Person.